143 related articles for article (PubMed ID: 18030586)
1. Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases.
Kim MS; Sim YS; Lee SY; Jeon DG
Ann Nucl Med; 2007 Nov; 21(9):529-32. PubMed ID: 18030586
[TBL] [Abstract][Full Text] [Related]
2. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
[No Abstract] [Full Text] [Related]
3. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
[TBL] [Abstract][Full Text] [Related]
4. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.
Are C; Hsu JF; Ghossein RA; Schoder H; Shah JP; Shaha AR
Ann Surg Oncol; 2007 Nov; 14(11):3210-5. PubMed ID: 17713821
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
6. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
[TBL] [Abstract][Full Text] [Related]
7. Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics.
Law TT; Lang BH
Ann Surg Oncol; 2011 Feb; 18(2):472-8. PubMed ID: 20740320
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
[TBL] [Abstract][Full Text] [Related]
9. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
10. [Pathological thyroid uptake in Cushing's syndrome: an unexpected finding].
Civantos Modino S; Montaño Martínez J; Pavón de Paz I; Guijarro de Armas G; Monereo Megías S
Endocrinol Nutr; 2011; 58(6):315-7. PubMed ID: 21497569
[No Abstract] [Full Text] [Related]
11. Combined parathyroid adenoma and an occult papillary carcinoma.
Meshikhes AW; Butt SA; Al-Saihati BA
Saudi Med J; 2004 Nov; 25(11):1707-10. PubMed ID: 15573208
[TBL] [Abstract][Full Text] [Related]
12. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma.
Cohen T; Krausz Y; Nissan A; Ben-Yehuda D; Klein M; Freund HR
Isr Med Assoc J; 2006 Oct; 8(10):720-1. PubMed ID: 17125126
[No Abstract] [Full Text] [Related]
14. Simultaneous existence of papillary carcinoma in the thyroid gland and thyroglossal duct cyst in two patients.
Demir D; Süoğlu Y; Güven M; Kapran Y
Kulak Burun Bogaz Ihtis Derg; 2005; 15(3-4):78-82. PubMed ID: 16340297
[TBL] [Abstract][Full Text] [Related]
15. [Incidental detection of a papillary thyroid cancer by ¹⁸F-FDG PET-CT study in a patient with metastatic colorectal cancer].
Banzo J; Ubieto MA; Villalta J; Razola P; Prats E; Andrés A
Rev Esp Med Nucl; 2010; 29(6):312-3. PubMed ID: 20826040
[No Abstract] [Full Text] [Related]
16. Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.
Kraeber-Bodéré F; Cariou B; Curtet C; Bridji B; Rousseau C; Dravet F; Charbonnel B; Carnaille B; Le Néel JC; Mirallié E
Surgery; 2005 Dec; 138(6):1176-82; discussion 1182. PubMed ID: 16360406
[TBL] [Abstract][Full Text] [Related]
17. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
18. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
Ong SC; Ng DC; Sundram FX
Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
[TBL] [Abstract][Full Text] [Related]
19. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation.
Davis PW; Perrier ND; Adler L; Levine EA
Am Surg; 2001 Jun; 67(6):582-4. PubMed ID: 11409808
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
